Share this @internewscast.com

Melanoma awareness: What to know and what to look for


Melanoma awareness: What to know and what to look for

04:28

A vaccine shows promising results in treating the most deadly form of skin cancer, Moderna and Merck announced on Thursday.

Those with severe melanomas who received the vaccine and Merck’s cancer drug Keytruda were 49% less likely to die or have their cancer come back after three years than those who were given only Keytruda, the biotech companies said in a news release. 

The companies have begun Phase 3 trials of mRNA-4157 with Keytruda, given a breakthrough therapy designation by the Food and Drug Administration earlier this year. The designation is meant to expedite the development and review of drugs meant to treat life-threatening diseases.

“We look forward to sharing these data with people impacted by the disease and the broader scientific community,” Kyle Holen, M.D., Moderna’s senior vice president and head of development, therapeutics and oncology, stated.


Skin cancer screening, safe sun exposure promoted on Melanoma Monday

03:00

The results are a vindication of sorts for Moderna’s strategy to develop new uses for messenger RNA technology used in its COVID-19 vaccine. Cambridge, Massachusetts-based Moderna said in November it anticipates a steep decline in revenue next year, fueling worries about its capacity to finance multiple product launches planned for 2024 and 2025.

Skin cancer is the most common form of cancer, with melanoma accounting for only about 1% of skin cancer cases in the U.S. That said, it causes a large majority of skin cancer deaths, according to the American Cancer Society. It estimates about 97,610 new melanomas will be diagnosed in the U.S. this year, resulting in 7,990 deaths.

Moderna’s stock has cratered this year, falling 50%. On Thursday, its shares shot up 12% in mid-day trading to $87.93. 

Rahway, New Jersey-based Merck shares treaded water, down 0.2% at $106.16.


Share this @internewscast.com
You May Also Like

Warning: Common Procedure May Increase Risk of Ultra-Deadly ‘Widow-Maker’ Heart Attack for Thousands

Thousands of people with the most dangerous type of heart disease could suffer…

Warning: Extended Sleep Might Increase Mortality Risk; Study Highlights Optimal Two-Hour Window

Researchers have discovered a connection between sleep duration and mortality risk. And…

Wrexham Nursing Home Owner Shares with Covid Inquiry: Staff Were Terrified Due to Lack of Testing

A woman whose husband killed himself amid the pressure of running a…

You’ve Been Misusing Your Fan – Learn the Right Way to Stay Cool

Over the weekend the UK saw temperatures hit as high as 34…

Doctor Cautions Against a Bedtime Routine That May Increase Dementia Risk

Falling asleep to the soothing sound of white noise could lead to…

UK Achieves Cancer Breakthrough with Blood Test to Tailor Treatments

UK scientists have created a blood test that reveals exactly how active…

Comprehending Parkinson’s Disease Progression: What to Anticipate in Each Stage

Have you ever thought about how someone’s body gradually begins to fail…

New Concerns Arise as Doctors Observe Rapid Increase in Cancer Rates, Outpacing Colon Cancer – Popular Food Item May Be Linked

Experts have warned of an alarming surge in a little-known type of…

Daily Consumption of Favorite Canned Food Led to Poisoning – Discovering the Shocking Safety Limits

An office worker has claimed eating tuna three times a day for…

Study Reveals Brits Neglecting Key Element of Dental Care Routine

A shocking four in ten Brits are neglecting  their gum health, focusing…

Researchers Identify New Cause of Aggressive Cancer in Youths and Potential Treatment

A little-known molecule in the body may be the key to treating…

How Profit-Driven Companies Might Influence the Quality of Care You Receive from Medical Professionals: A Perspective by John Naish

Would you trust NHS screening tests if it turned out they weren’t…